Below please find all presentations and posters generated by the High-Throughput Molecular Screening Center and its scientific staff. If you are interested in viewing a presentation or poster, please click on the linked file or send a request e-mail to Scripps-UFL-HTS@mail.ufl.edu to see if it is available.
There are currently 217 posters and presentations listed below.
217 – Spicer T
October 2024
Leveraging Drug Discovery Technologies to Create More Physiologically Relevant Models of Disease
3D Cell Culture Summit
San Francisco, CA, USA
216 – Spicer T
September 2024
An Inside View of the UF Scripps Biomolecular Research Screening
UF College of Medicine 2024 Retreat
Gainesville, FL, USA
215 – Doonan B, Spicer T, Rahman M, Scampavia L, Fernandez-Vega V, Benslimane N, Mctiernan R, Roemeling C, Mitchell D.
August 2024
Personalized Treatment of Melanoma Brain Metastases Through High Throughput Drug Screening
2024 SNO/ASCO CNS Metastases Conference
Denver, CO, USA
PMC11296757
214 – Scampavia L
July 2024
Chemo-Drug Response Profiling Against Patient-Derived Glioblastomas
Best of American Society of Clinical Oncology 2024 Miami Symposium
Miami, FL, USA
213 – Spicer T
May 2024
Uncovering Methods to Support High-Throughput Screening
3D Tissue Models Summit
Boston, MA, USA
212 – Spicer T
April 2024
Partnering for Precision Onclogy to Treat Brain Cancer
Florida Academic Cancer Center Alliance
Jupiter, FL, USA
211 – Spicer T
February 2024
Chemoresponse Profiling of Patient Derived GBM for Precision Oncology
UF Health Cancer Center – UF Scripps Research Retreat
Jupiter, FL, USA
210 – Fernandez-Vega V
February 06, 2024
Identification of Small Molecule Inhibitors of hyperphosphorylated tau (p-tau) Aggregation Via High Throughput Screening
SLAS 2024 International Conference and Exhibition
Boston, MA
209 – Otsuka Y
February 05, 2024
Midwest AViDD HTS for SARS-CoV-2
Helicase Inhibitors
SLAS 2024 International Conference and Exhibition
Boston, MA
208 – Shumate J, Spicer T, Scampavia L.
February 05, 2024
Developments in Quadruplexing Microplate Assays: From 1536 to 6444 Assays in a Standard Microplate
SLAS 2024 International Conference and Exhibition
Boston, MA
207 – Pena J, Smith E, Hawkins R, Emerine C, Lee B, Scampavia L, Spicer T.
February 05, 2024
Natural Product Compound Fractionization of the Lion’s Mane Mushroom and HTS Analysis of its Effects on Multiple Models of Neuronal Disorders
SLAS 2024 International Conference and Exhibition
Boston, MA
206 – Smith E, Geng Q, Shumate J, Otsuka Y, Scampavia L, Li F, Spicer T.
February 05, 2024
SARS2 Entry Helix Bundle HTS Campaign
SLAS 2024 International Conference and Exhibition
Boston, MA
205 – Spicer T
February 05, 2024
Case Studies: Phenotypic Screening of Complex Neuronal Models of Disease
SLAS 2024 International Conference and Exhibition
Boston, MA
204 – Spicer T, Nag M, Tiriac H, Plenker D
February 04, 2024
What can geometry do for you? – A practical, “how to” toolbox for the development of physiologically relevant 3D models
SLAS 2024 International Conference and Exhibition
Boston, MA
203 – Spicer T
October 04, 2023
In-vitro Analysis of Autism Spectrum Disorder using Induced Human Neurons and AI
Future Labs Live 2023
Philadelphia, PA
202 – Fernandez-Vega V, Ortiz L, Scampavia L, Spicer T
July 12, 2023
Outsmarting Cancer | Research Detectives
PBS – AllHealthGo
Jupiter, FL
201 – Spicer T
May 19, 2023
Chemoresponse Profiling Using 3D Primary Tumor Models
UF Preston A. Wells, Jr. Center for Brain Tumor Therapy
Gainesville, FL
200 – Spicer T
April 21, 2023
Closing Keynote: Chemoresponse Profiling Using 3D Primary Tumor Models
SLAS 2023 Building Biology in 3D Symposium
Cambridge, UK
199 – Chung D, Otsuka Y, Shumate J, Park HJ, Kim E, Demir O, Li J, Marecki J, Spicer T, Scampavia L, Bannister T, Amaro R, Head-Gordon T, Raney K
March 13, 2023
Discovery of a Novel SARS-CoV2 Helicase Inhibitor From a HTS Campaign
International Conference on Antiviral Research 2023
Lyon, FR
198 – Nakashima J, Rajan R, Fernandez-Vega V, Sperry J, Yan D, Carapia B, . . . Spicer T
February 27, 2023
Development of In Vitro and In Vivo Primary Tumor Models of Glioblastoma (GBM) to Preclinically Validate Combinatorial Approaches
SLAS 2023 International Conference and Exhibition
San Diego, CA, USA
197 – Otsuka Y, Smith E, Mou H, Davis-Gardner M, Mediouni S, Jablonski J, . . . Spicer T
February 27, 2023
Compendium of HTS of SARS-CoV2 Targets to Prepare for the Next Pandemic
SLAS 2023 International Conference and Exhibition
San Diego, CA, USA
196 – Pena J, Lee E, Ji K, Archasappawat S, Fernandez-Vega V, Kim M, Tian Q, Scampavia L, Hwang C, Spicer T
February 27, 2023
High Throughput Screening of KPC-Familial Pancreatic Cancer for Selective Inhibitors of BRCA2 Deficient Cells
SLAS 2023 International Conference and Exhibition
San Diego, CA, USA
195 – Ortiz L, Fernandez-Vega V, Shumate J, Peles A, Zeiger J, Scampavia L, Spicer T
February 27, 2023
Ultra-High Throughput Screening to Assess Oncologic Drug Effects in 3D Primary Melanoma and Renal Cell Carcinoma
SLAS 2023 International Conference and Exhibition
San Diego, CA, USA
194 – Smith E, Perez K, Scampavia L, Hernandez D, Spicer T
February 27, 2023
Adaptation of a Cell-based Kinetic Potassium Channel Assay to an Endpoint Assay on Common Plate Readers and Microscopes
SLAS 2023 International Conference and Exhibition
San Diego, CA, USA
193 – Spicer T
February 16, 2023
Chemoresponse Profiling for Precision Oncology
UF Health Cancer Center – UF Scripps Research Retreat
Jupiter, FL, USA
192 – Spicer T
November 15, 2022
Panelist: Leveraging Technology to Aid in Discovery
Future Labs Live, Raleigh Convention Center
Raleigh, NC, USA
191 – Spicer T
October 25, 2022
Technology Innovations at UF Scripps HTS Center Directed at Precision Medicine for Brain Cancer
University of Florida Biomedical Engineering
Gainesville, FL, USA
190 – Spicer T
October 14, 2022
Drug Response Profiling Using 3D Primary Tumor Models
University at Albany, Cancer Research Center
Albany, NY, USA
189 – Spicer T
May 25, 2022
Opening Conference and Exhibition Ceremonies and Keynote Introduction
SLAS Europe 2022 Conference and Exhibition
Dublin, IE
188 – Spicer T
May 10-12, 2022
Panelist: Creating Predictive 3D Models Using Cell Lines
PREDiCT: 7th Annual 3D Tissue Models Summit
Boston, MA, USA
187 – Spicer T
May 10-12, 2022
HTS of 3D Models and Assay Development Workshop
PREDiCT: 7th Annual 3D Tissue Models Summit
Boston, MA, USA
186 – Spicer T
April 26-27, 2022
Drug Response Profiling Using 3D Tumor Models
2022 Americas Building Biology in 3D Symposium
The Broad Institute Cambridge, MA, USA
185 – Scampavia L
February 10, 2022
3D uHTS Models for Chemo Response Profiling of Cancer
SMi 3D Cell Culture Virtual Conference
London, UK
184 – Shumate J
February 8, 2022
Developing Inexpensive, Open-Source Solutions to Automated Dispensing
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
183 – Fernandez-Vega V
February 9, 2022
3D Screening of Lung Cancer Spheroids using Natural Products
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
182 – Smith E
February 8, 2022
High Throughput Screening for Drugs that Inhibit 3C-Like Protease in SARS-CoV-2
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
181 – Baillargeon P
February 8, 2022
Leveraging Open Source Technology To Support High-Throughput Screening
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
180 – Scampavia L – Session Chair
February 8, 2022
Integrated and Iterative Automated Processes to enable Hit Discovery for the Future
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
179 – Fernandez-Vega V
February 8, 2022
Tumor Organoid and HTS Models for Precision Medicine and Novel Leads
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
178 – Scampavia L – Session Chair
February 7, 2022
Automating Screening Processes
SLAS 2022 International Conference and Exhibition
Boston, MA, USA
177 – Baillargeon P
November 22, 2021
The Impact of Open Source Technologies on Early Stage Drug Discovery Research
IEEE Palm Beach Section Monthly Virtual Meeting
Online Seminar
176 – Rajendra Rao S
November 19, 2021
In-Vitro Analysis of Austism Spectrum Disorder Using Induced Human Neurons and AI
Scripps ResearchFest Symposium 2021
Jupiter, FL, USA
175 – Ortiz Jordan L
November 19, 2021
A Novel 45 Degree Adapter for the 3D Spheroid and Organoid Formation Formation Using 1536 Cell Repellent Plates
Scripps ResearchFest Symposium 2021
Jupiter, FL, USA
174 – Otsuka Y
November 19, 2021
Targeting Covid-19 Using HTS Approaches
Scripps ResearchFest Symposium 2021
Jupiter, FL, USA
173 – Spicer T
November 17, 2021
HTS to Identify Inhibitors of Gram Negative Bacteria
Walter Reed Army Institute of Research (WRAIR) and Combating Antibiotic Resistant Bacteria (CARB)
Online Seminar
172 – Spicer T – Symposium Chair
October 26-27, 2021
SLAS 2021 Building Biology in 3D Symposium
La Jolla, CA, USA
171 – Spicer T
October 5, 2021
In vitro & In-vivo Primary Tumor Models of Glioblastoma (GBM) to Pre-clinically Validate Combinatorial Therapy Approaches
PREDiCT INNOVATION: Orthotopic PDX as a Superior Preclinical Model
Online Seminar
170 – Spicer T
September 9, 2021
Introduction to Implementing 3D Culture Models
Keynote Speech
Select Biosciences
Online Seminar
169 – Fernandez Vega V
June 16, 2021
Level Up: A Panel Discussion on 3 Dimensional Cultures in a High Throughput Environment
3D Cell Culture Virtual Summit, Corning 3D Cell Culture
Online Seminar
168 – Baillargeon P – Session Chair
January 27, 2021
In-House and Open Source Automation
SLAS2021 Digital International Conference and Exhibition
Online Seminar
167 – Spicer T
December 10, 2020
Scaling, Adapting, and validating Human iPSC-derived Neurons for High Throughput High Content Screening
Modern Methods in Life Science and Reporters in Drug Research – Examples how to reduce the number of animals and increase the research quality
University of Helsinki
Online Seminar
166 – Rajendra Rao S
October 23, 2020
Small Molecule Rescue of Phenotypes Disrupted in Autism Spectrum Disorder
2020 Scripps ResearchFest
Online Seminar
165 – Otsuka Y
October 21, 2020
Identification and Validation of Drugs that Inhibit SARS-CoV-2 Entry
2020 Scripps ResearchFest
Online Seminar
164 – Scampavia L, Spicer T
October 19, 2020
High Throughput Screening for Drug Discovery and 3D Models of Cancer for Precision Medicine Therapeutic Profiling
University of Miami Health Sylvester Comprehensive Cancer Center Shared Resources Advanced Biomedical Technology Seminar
Online Seminar
163 – Fernandez Vega V
September 16, 2020
3D Models of Brain Cancer for Precision Medicine Therapeutic Profiling
Discovery On Target
Online Seminar
162 – Otsuka Y
September 14, 2020
Identification and Validation of Drugs that Inhibit SARS-CoV-2 Entry
Scripps Research – Molecular Medicine Department Retreat
Online Seminar
161 – Rajendra Rao S
September 14, 2020
Small Molecule Rescue of Phenotypes Disrupted in Autism Spectrum Disorder
Scripps Research – Molecular Medicine Department Retreat
Online Seminar
160 – Spicer T
September 14, 2020
Chem Response Profiling Utilizing Patient Derived Pancrease and Brain Tumors
Scripps Research – Molecular Medicine Department Retreat
Online Seminar
159 – Spicer T
September 11, 2020
Leveraging Biotechnology at the Scripps Research Molecular Screening Center via Extramural Collaborations
MSU Drug Discovery Seminar Series
Online Seminar
158 – Baillargeon P
January 29, 2020
Leveraging Open Source Electronics for Rapid Development of Custom Laboratory Devices
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
157 – Fernandez-Vega V – Session Chair
January 28, 2020
Advanced In Vitro Cell Culture Systems
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
156 – Spicer T
January 28, 2020
Drug Combination and Gene Network Analysis in 3D Models of Brain and Pancreas Cancer Towards Precision Medicine
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
155 – Smith E
January 28, 2020
A Homogeneous Cell-Based Membrane Potential Assay to Identify Compounds That Promote Readthrough of Premature Termination Codons in the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
154 – Baillargeon P
January 28, 2020
Development of Open Source Microplate Illumination Panels
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
153 – Shumate J
January 27, 2020
A Web-Based Tool for Real-Time Monitoring of High-Throughput Screening Results
SLAS 2020, 9th Annual Conference & Exhibition
San Diego, CA, USA
152 – Scampavia L, Spicer T
January 27, 2020
Leveraging Biotechnology at the Scripps Research Molecular Screening Center and Examples/Mechanism for Multi-Institute Collaborations
Faculty Presentation
La Jolla, CA, USA
151 – Rajendra Rao S
January 24, 2020
Scaling Human Neurons for HTS to Identify Molecules that Rescue the Wildtype Neuronal Phenotype that is Disrupted in Autism Spectrum Disorder
Synapse 2020
Jupiter, FL, USA
150 – Spicer T
November 22, 2019
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
20th Annual Innovative Molecular Analysis Technologies Principal Investigators Meeting
Los Angeles, CA, USA
149 – Baillargeon P
November 20, 2019
Optimizing Processes using In-House Engineering to Innovate Automation and Sample Management
2019 SLAS Sample Management Symposium
Boston, MA, USA
148 – Baillargeon P
November 1, 2019
Development of Open Source Microplate Illumination Panels
2019 Scripps ResearchFest
Jupiter, FL, USA
147 – Spicer T
May 9, 2019
Integration of 3D primary tumor drug-profiling with patient-specific drug gene networks for recommending targeted cancer therapies.
3D Oncology Models Conference
Boston, MA, USA
146 – Spicer T
April 3, 2019
3D Primary Cancer Models for Phenotypic Drug Discovery Applications
AACR Exhibitor Spotlight Presentation: Magnetic 3D Bioprinting, High-Throughput Screening Platform to Advance Cancer Research
Atlanta, GA, USA
145 – Spicer T
February 7, 2019
3D Primary Cancer Models for Phenotypic Drug Discovery Applications
National Cancer Institute Lecture
Rockville, MD, USA
144 – Shumate J
February 6, 2019
Open-Source Solution for Wireless Monitoring of Laboratory-Based Climate-Controlled Environments
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
143 – Spicer T
February 6, 2019
Academic Drug Discovery Special Interest Group (SIG)
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
142 – Smith E
February 5, 2019
Assay Development and HTS implementation for the Identification of Activators of a Master Regulator Gene Down Modulated in HIV-Associated Neurodegeneration
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
141 – Scampavia L
February 5, 2019
Data Directed Approach for Diversity-based HTS library design
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
140 – Fernandez Vega V
February 5, 2019
Fully Automated Large Scale uHTS using 3D Cancer Organoid Models for Phenotypic Drug Discovery Applications
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
139 – Baillargeon P
February 5, 2019
A longitudinal analysis over 10 years of enabling technologies for early drug discovery using open source tools
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
138 – Smith E
February 4, 2019
Maxcyte Electroporation System Enables Homogeneous uHTS For Cell-Based Assays Across Multiple Detection Platforms
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
137 – Sridharan B
February 4, 2019
A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
136 – Sridharan B
February 4, 2019
Thermo Fisher Scientific Exhibitor Tutorial: Addressing the Scalability of Human iPSC-derived Neurons for HTS Implementation and Phenotypic Screening
SLAS 2019, 8th Annual Conference & Exhibition
Washington D.C., USA
135 – Spicer T
November 29, 2018
Advanced Development and Validation of 3-Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
2018 National Cancer Institute – Innovative Molecular Analysis Technologies Annual PI Meeting
Rockville, MD, USA
134 – Sridharan B
September 17, 2018
Addressing the Scalability of Human iPSC-derived Neurons for HTS Implementation and Phenotypic Screening
6th annual 24 Hours of Stem Cells virtual event
133 – Spicer T
June 26, 2018
Scaling, Adapting, and CRISPR editing Human iPSC-derived Neurons for High Throughput and High Content Screening
Icahn School of Medicine at Mount Sinai
New York, NY, USA
132 – Spicer T
June 25, 2018
3D Platforms in High Throughput Formats to Assess the Cytotoxic Effect of Drugs on Cancer
Stony Brook Medicine
Stony Brook, NY, USA
131 – Scampavia L
June 25, 2018
Introduction to Scripps Florida HTS and Strategies for the Discovery and Advancement of Small Molecule Drug-like Leads
Stony Brook Medicine
Stony Brook, NY, USA
130 – Spicer T
May 9, 2018
A Comparative Analysis of 3D Platforms in High Throughput Formats to Assess the Cytotoxic Effect of Drugs for Discovery
3D Tissue Models Oncology 2018
Boston, MA, USA
129 – Spicer T
March 8, 2018
“3 Dimensional Approaches to Identify Potential Cancer Therapies”
Taras Oceanographic Institute and Jupiter Environmental Research and Science Academy, Jupiter High School
Jupiter, FL, USA
128 – Baillargeon P
February 7, 2018
“In-house software and processes to support High-Content Screening of Primary Neurons”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
127 – Smith E, Giuliano K, Shumate J, Baillargeon P, McEwan B, Cullen D, Miller J, Drew L, Scampavia L, Spicer T
February 7, 2018
“A Homogeneous Cell-Based Halide-Sensitive YFP Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
126 – Shumate J, Baillargeon P, Spicer T, Scampavia L
February 7, 2018
“IoT for Real-Time Measurement of High-Throughput Liquid Dispensing in Laboratory Environments”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
125 – Spicer T
February 6, 2018
“Hapatotoxicity Determination Using 3D Primary Human Hepatocyte Culture Systems”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
124 – Sridharan B
February 5, 2018
“Development of Cellular Models for Phenotipic Screening”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
123 – Hou S, Baillargeon P, Souza G, Seldin J, Feist F, Scampavia L, Spicer T
February 5, 2018
“Validation of Magnetic 3D Spheroid Bioprinting in Combination with a BlueWasher”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
122 – Hou S
February 5, 2018
“Primary Cell 3D Pancreatic Cancer Organoid Models for Phenotypic High-Throughput Therapeutic Screening”
SLAS 2018, 7th Annual Conference & Exhibition
San Diego, CA, USA
121 – Spicer T
December 6-8, 2017
“Advanced Development and Validation of 3D Spheroid Culture of Primary Cancer Cells using Nano3D Technology”
2017 National Cancer Institute – Innovative Molecular Analysis Technologies Annual PI Meeting
Rockville, MD, USA
120 – Spicer T
November 4, 2017
“Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus”
International Conference on Diabetes and its Complications
Baltimore, MD, USA
119 – Hou S, Sridharan B, Triac H, Scampavia L, Watson D, Seldin J, Souza G, Tuvenson D, Spicer T
September 14, 2017
“Implementation of 3D Pancreatic Cancer Organoid Models for High Throughput Phenotypic Drug Screening”
International Conference on Diabetes and its Complications
San Diego, CA, USA
118 – Singhera F
August 30, 2017
“Scripps Technology and Vendor Partnerships Enabling Early Drug Development”
13th IQPC Compound and Sample Management Summit
Philadelphia, PA, USA
117 – Singhera A
August 28, 2017
“What’s Next in Tech? Future Proofing your Compound & Sample Management Staff & Systems”
13th IQPC Compound and Sample Management Summit
Philadelphia, PA, USA
116 – Spicer T
June 2017
“3D Primary Tumor Cell Organoid Models for Phenotypic High-throughput Screening”
Mount Sinai School of Medicine
New York, NY, USA
115 – Hou S
February 8, 2017
“Identification of KRAS Mutant Selective Inhibitors of Pancreatic Cancer Cell Growth Via Parallel Phenotypic High-throughput Screening of Approved Drugs”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
114 – Fernandez Vega V
February 8, 2017
“Retrospective Analysis of 18 Activity Based Protein Profiling HTS Assays for the Identification of Selective Inhibitors of Disease Relevant Enzymes”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
113 – Smith E, Jambrina E, Cerne R, Scampavia L, Cuadrado M, Findlay J, Krambis M, Wakulchik M, Chase P, Brunavs M, Burris K, Gallagher P, Ursu D, Spicer T
February 7, 2017
“Fully Automated Robotic Screening for the Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptor Using Calcium Flux Assays”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
112 – Spicer T
February 7, 2017
“3-Dimensional Cell Culture Systems, Novel Technologies, and Their Use at the Laboratory Bench”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
111 – Scampavia L
February 7, 2017
“Fragment-Based Assisted HTS: Novel Approach to Traditional Drug Discovery”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
110 – Baillargeon P, Scampavia L, Spicer T
February 6, 2017
“Fragment-Based Assisted HTS: Novel Approach to Traditional Drug Discovery”
SLAS 2017, 6th Annual Conference & Exhibition
Washington D.C., USA
109 – Spicer T
February 6, 2017
“TSRI-Drug Discovery Graduate Course-Spicer Lecture”
Scripps Research Institute Molecular Screening Center
Jupiter, FL, USA
108 – Scampavia L
February 6, 2017
“Compound Library & Informatics for HTS Screening”
Scripps Research Institute Molecular Screening Center
Jupiter, FL, USA
107 – Spicer T
August 31, 2016
“Examining How the HTS Storage & Microplate Industry has Effected Translational Science & Precision Medicine”
12th Compound & Sample Management Summit
Philadelphia, PA, USA
106 – Baillargeon P, Southern M, Spicer T, Scampavia L
January 25, 2016
“HTS Dashboard: a unified web-based toolset to streamline HTS informatics”
SLAS 2016, 5th Annual Conference & Exhibition
San Diego, CA, USA
105 – Smith E, Janovick J, Scampavia L, Conn P, Spicer T
January 25, 2016
“Identification of Potential Pharmacoperones using a Cell-based 1536 Well High Throughput Screening Campaign Capable of Rescuing the Functionality of Mutant Misfolded V2R”
SLAS 2016, 5th Annual Conference & Exhibition
San Diego, CA, USA
104 – Madoux F
January 26, 2016
“Enabling 3D Cell-based Spheroid HTS Assays in 384 and 1536-well Plate Formats”
SLAS 2016, 5th Annual Conference & Exhibition
San Diego, CA, USA
103 – Spicer T
January 27, 2016
“An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays”
SLAS 2016, 5th Annual Conference & Exhibition
San Diego, CA, USA
102 – Spicer T
October 27, 2015
“Leveraging Biotechnology at The Scripps Research Institute Molecular Screening Center and Examples/Mechanism for Multi-Institute Collaborations”
Department of Pharmacology & Systems Therapeutics and Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai
New York, NY, USA
101 – Spicer T
September 24, 2015
“Live/dead Assays for the Purpose of Discovering Molecular Probes that May Inhibit Plasmodium falcipraum Gametocytes”
Department of Molecular Therapeutics
Jupiter, FL, USA
100 – Madoux F, Smith E, Fernandez-Vega V, Shumate J, Scampavia L, Spicer T
September 14-17, 2015
“10 Years of Ultra-high Throughput Screening using HTRF Technology; a Retrospective”
HTRF Symposium
Brewster, MA, USA
99 – Baillargeon P, Madoux F, Southern M, Chase P, Hodder P, Spicer T, Scampavia L
February 9, 2015
“Leveraging Software to Enable Wells-to-Cells High Content Analysis (HCA) for High Throughput Screening (HTS)”
SLAS 2015, 4th Annual Conference & Exhibition
Washington D.C., USA
98 – Smith E
February 9, 2015
“Parallel Screening of Multiple Muscarinic Receptors Using Multiparametric Cell-Based Assays”
SLAS 2015, 4th Annual Conference & Exhibition
Washington D.C., USA
97 – Spicer T
February 9, 2015
“Utility of the MaxCyte at the SRIMSC”
SLAS 2015, 4th Annual Conference & Exhibition
Washington D.C., USA
96 – Madoux F, Kota S, Scampavia L, Garen P, Kissil J, Spicer T
January 18, 2015
“Building Phenotypic 3D Spheroid HTS Assays to Identify Synthetic Lethal Small Molecule Inhibitors of KRas”
Miami Winter Symposium 2015 Towards Personalized Cancer Medicine
Miami, FL, USA
95 – Baillargeon P
February 28, 2014
“Robotics and Laboratory Automation at Scripps Florida”
FAU Novel Engineering Research and Development Society
Boca Raton, FL, USA, Florida Atlantic University
94 – Lovell KM, Zhou L, Frankowski KJ, Slauson SR, Phillips AM, Streicher JM, Stahl E, Schmid CL, Hodder P, Madoux F, Cameron MD, Prisinzano TE, Aube J, Bohn LM
November 12-16, 2013
“Evaluation of Functionally Selective Kappa Opioid Receptor (KOR) Ligands”
SERMACS 2013
Atlanta, GA, USA
93 – Madoux F
February 20, 2014
“Enabling High-Content Assays in the 1,536-Well Plate Format: A Practical, Stepwise Description”
High-Content Analysis Conference, Podium Presentation
La Jolla, CA, USA
92 – Madoux F, Abovich A, Baillargeon P, Chase P, Southern M, Rosen H, Scampavia L, Spicer T, Hodder P
February 19-20, 2014
“1536-Well Plate High Content Assays to Monitor S1P1 (EDG1) Activation”
High-Content Analysis Conference
La Jolla, CA, USA
91 – Scampavia L
January 21, 2014
“Integrating Cutting-Edge Technologies that Enable High-Throughput Automation for Compound Library QC Management”
SLAS 2014 3rd Annual Conference & Exhibition, Podium Presentation, Automation & High Throughput Technologies
San Diego, FL, USA
90 – Madoux F
April 24, 2013
“Academia/Industry Cross-Fertilization through Translational Research”
5th Annual Symposium: HTRF® in Drug Discovery
Avignon, France
89 – Baillargeon P
January 15, 2013
“Plate Auditor: Monitoring Sample Quality and Providing Valuable Information to Aid Decision Making in Compound Management and HTS”
SLAS 2013 2nd Annual Conference & Exhibition, Brooks Workshop/Tutorial
Orlando, FL, USA
88 – Baillargeon P, Eberhart C, Chase P, Hodder P
January 14, 2013
“A Novel Method for Documentation and Measurement of Manufacturing Defects in Compound Storage Plates”
SLAS 2013 2nd Annual Conference & Exhibition
Orlando, FL, USA
87 – Hodder P
January 14, 2013
“HTS and Early Drug Discovery in Industry and Academia. Collaboration: Is the Sum Greater Than the Two Parts?”
SLAS 2013 2nd Annual Conference & Exhibition, Special Session
Orlando, FL, USA
86 – Lewallen D, Chase P, Madoux F, Hodder P, Thompson PR
October 25, 2012
“Developing an HTS Screen to Discover VopS Inhibitors”
TSRI Research Fest
Jupiter, FL, USA
85 – Baillargeon P
September 20, 2012
“Expanding the Compound Management Tookit: Leveraging Technology to Streamline Sample QA/QC in High Throughput Environments”
8th IQPC Compound Management & Integrity Summit
Cambridge, MA, USA
84 – Trenholme KR, Peatey CL, Spicer T, Hodder P, Gardiner DL
July 5-9, 2012
“Plasmodium falciparum gametocytes: With a View to a Kill”
Australian Society for Parasitology Annual Conference
Launceston, Tasmania, Australia
83 – Hodder P
May 30, 2012
“The Impact of Rapid, Automated Analysis of HTS Library Sample Quality”
European Lab Automation
Hamburg, Germany
82 – Ranade RM, Gillespie JR, Lohse J, Brown SJ, Pedró Rosa LE, Madoux F, Hodder P, Shibata S, Li J, Koh CY, Kim J, Van Der Schueren WJ, Verlinde CL, Hol WG, Fan E, Buckner FS
May 17, 2012
“Optimization of Methionyl-tRNA Synthetase from Trypanosoma brucei for High-Throughput Screening”
Seattle Parasitology Conference
Seattle, WA, USA
81 – Baillargeon P
February 9, 2012
“Addressing HTS Compound Quality Control”
Brooks Life Science Systems User Meeting
San Diego, CA, USA
80 – Baillargeon P
February 6, 2012
“A Novel Platform to Improve HTS Compound Management Operations”
SLAS 2012 1st Annual Conference & Exhibition
San Diego, CA, USA
79 – Baillargeon P
November 9, 2011
“Quality Control Issues in Day-to-Day HTS Compound Management Operations”
Compound Management & Integrity Online 2011
78 – Fernandez-Vega V
March 30, 2011
“Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (AAP) of Human Malaria Identified via a QFRET uHTS Campaign”
SBS 17th Annual Conference and Exhibition
Orlando, FL, USA
77 – Spicer T
March 30, 2011
“Identifying Helicobacter pylori AddAB DNA Repair Enzyme Inhibitors Using a Novel Bacteriophage E. Coli Infectivity Assay in Highly Miniaturized Formats”
SBS 17th Annual Conference and Exhibition
Orlando, FL, USA
76 – Spicer T
January 31, 2011
“A Brief Introduction to Scripps Florida’s Drug Discovery Capabilities & Anti-Infective Research”
Optimizing Detection, Prevention, & Treatment of Vector-Borne Diseases
Orlando, FL, USA, Sanford/Burnham Medical Research Insitute
75 – Hodder P, Bernasconi P
2011
“Co-Chair welcome to Scientific Program of the Society for Laboratory Automation and Screening SBS 2011”
Opening General Session, SBS 17th Annual Conference and Exhibition
Orlando, FL, USA
74 – Hodder P
December 16, 2010
“ASK THE EXPERT Webcast Series: What You Should Know When Setting Up A Cell Culture Lab”
Lab Manager Magazine Webinar
73 – Scampavia L
December 7, 2010
“Integrating LCMS Automation for HTS Compound Management”
The Compound Management Forum
Providence, RI, USA
72 – Hodder P
November 10, 2010
“Relevant, Publicly Available Chemical Probes Resulting from HTS Efforts”
Gyeonggi, South Korea, Gyeonggi Institute of Science & Technology Promotion (GSTEP)
71 – Hodder P
November 9, 2010
“Convergent Technologies & Paradigms that Facilitate Rapid Lead Identification from High-Throughput Screening Efforts”
G20 International Symposium on Convergence Technologies, Improving the Quality of Living
Seoul, South Korea
70 – Hodder P
November 8, 2010
“Facilitating Rapid Lead Identification from HTS Campaigns via Parallel Screening”
Daejeon, South Korea, Korea Research Institute of Chemical Technology (KRICT)
69 – Hodder P
October 18, 2010
“Scripps’ Screening Efforts: Relevant, Publicly Available Chemical Probes Resulting from HTS Efforts”
SBS Symposium, Biomolecular Screening Advanced Applications Across Academia, Government & Industry
Durham, NC, USA
68 – Madoux F
September 28-29, 2010
“A Newly Identified Chemical Probe Reveals a Novel Kinase Inducing Wee1 Degradation”
Probe Discovery Conference
Washington, DC, USA
67 – Baillargeon P
August 23-24, 2010
“Evolution of Compound Management Software at Scripps Florida”
2nd Annual Drug Discovery: Easing the Bottleneck
Philadelphia, PA, USA
66 – Hodder P, Baillargeon P
April 16, 2010
“The Impact of the REMP SSS on Scripps Florida’s Medicinal Chemistry Support Operations”
REMP User Meeting
Phoenix, AZ, USA
65 – Hodder P
April 2010
“A Parallel Screening Paradigm Facilitates Rapid Lead Identification from HTS Campaigns”
SBS 16th Annual Conference and Exhibition
Phoenix, AZ, USA
64 – Volmar CH, Saldanha SA, Honkanen R, Swingle M, Chase P, Eberhart C, Hodder P
April 2010
“Identification of Protein Phosphatase Inhibitors by Fluorescence-Based Biochemical Ultra High Throughput Screening Assay”
SBS 16th Annual Conference and Exhibition
Phoenix, AZ, USA
63 – Knapinska A, Madoux F, Chase P, Eberhart C, Spicer T, Mercer B, Harding H, Hodder P
April 2010
“In Search of New Antifungal Agents: Ultra High Throughput Screening for TPT1 Inhibitors”
SBS 16th Annual Conference and Exhibition
Phoenix, AZ, USA
62 – Fernandez-Vega V, Spicer T, Crisp M, Chase P, Eberhart C, Bachovchin DA, Brown S, Rosen H, Cravatt BF, Hodder P
April 2010
“Ultra-High-Throughput Screening of Poorly Characterized Enzymes via Fluorescence Polarization – Activity Based Protein Profiling (FP-ABPP)”
SBS 16th Annual Conference and Exhibition
Phoenix, AZ, USA
61 – Baillargeon P
February 2010
“Drug Discovery Automation”
Scripps Florida Education Outreach Program
Riviera Beach, FL, USA, Suncoast Community High School
60 – Hodder P
2010
“Academic Collaborations That Impact Translational Research”
BioFlorida
Ft. Lauderdale, FL, USA
59 – Hodder P
2010
“Introduction to Scripps Florida & HTS Collaboration Opportunities”
Guest Speaker, USDA
Ft. Pierce, FL, USA
58 – Walker SR, Nelson EA, Chaudhury M, Madoux F, Subramaniam P, Chase P, Koenig M, Roush WR, Hodder P, Frank DA
2010
“Preclinical Evaluation of a STAT3 Inhibitor in Breast Cancer”
The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, presented by Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine
San Antonio, TX, USA
57 – Hodder P
2010
“Parallel Screening of Target and Anti-Target Accelerates the Hit-to-Lead Effort”
World Pharmaceutical Congress Conference
Philadelphia, PA, USA
56 – Hodder P
2010
“Intro to HTS and its Impact on Drug Discovery”
NYU Polytechnic Institute Alumni Event
Jupiter, FL, USA
55 – Agnieszka B, Crisp M, Schuerer S, Mercer B, Hodder P, Roush W, Yang VW
2010
“High-Throughput Screening (HTS) of a 290,000-Small Molecule Compound Library for Inhibitors of the Gene Encoding the Pro-proliferative Human Kruppel-Like Factor 5 (KLF5)”
Digestive Disease Week (DDW)
Atlanta, GA, USA
54 – Griffin PR, Kumar N, Nuhant P, Busby S, Chalmers M, Zhang J, Conkright J, Wang Y, Roth J, Madoux F, Hodder P, Burris TP, Roush W
2010
“Profiling of Nuclear Receptor Modulators”
Targets & Tools: Nuclear Receptors
Berlin, Germany
53 – Minond D
November 19-20, 2009
“Developing Publicly-Available Chemical Tools for the Scientific Research Community: Four Case Studies”
Probe Discovery
La Jolla, CA, USA
52 – Hodder P
March 2009
“Introduction to Drug Discovery: Principles and Practices”
Coffee with the Professor
Jupiter, FL, USA, Florida Atlantic University
51 – Hodder P
2009
“Scripps Florida Lead Identification: Where Robotics, Chemistry and Biology Join Forces to Help Discover New Drugs”
BioFlorida
Orlando, FL, USA
50 – Saldanha SA, Brothers S, Spicer T, Chase P, Wahlestedt C, Hodder P
2009
“Parallel FLIPRTETRA HTS Campaigns for NPY Antagonists Yields Selective NPY-Y2 (Y2R) Small Molecule Probes”
Discovery on Target
Boston, MA, USA
49 – Baillargeon P, Hodder P
2009
“Drug Discovery Automation”
Florida Conference on Recent Advances in Robotics (FCRAR) ’09
Jupiter, FL, USA
48 – Hodder P
2009
“Science in Action: The Scripps Research Institute – Scripps Florida”
Bank of America Moody’s Investors Service
Jupiter, FL, USA
47 – Spicer T
2009
“Biotechnology at Scripps Florida”
Jupiter, FL, USA, Taras Oceanographic Institute
46 – Doghman M, Cazareth J, Douguet D, Madoux F, Hodder P, Lalli E
2009
“Inhibition of Human Adrenocortical Carcinoma Cells Proliferation by SF-1 Inverse Agonists”
91st Annual Meeting of the Endocrine Society
Washington, D.C., USA
45 – Madoux F, Simanski S, Chase P, Ayad N, Hodder P
2009
“Ultra-High-Throughput Screening for Inhibitors of Wee1 Kinase Degradation Using Transiently Transfected, Frozen Assay-Ready Cells”
15th Annual Society for Biomolecular Sciences Conference & Exhibition
Lille, France
44 – Grimm C, Saldanha SA, Oshima K, Jörs S, Hodder PS, Heller S
2009
“High-Throughput Drug Screening for Agonists of TRPML3 and TRPN1, Two Sensory Hair Cell Cation Channels of Unknown Function”
3rd RSC BMCS Ion Channel Symposium
Novartis, Horsham, UK
43 – Madoux F
September 24-26, 2008
“Investigating PPARγ Coactivator Recruitment by Parallel HTRF® Screens”
4th Annual Symposium: HTRF® in Drug Discovery
Avignon, France
42 – Schröter T, Minond D, Weiser A, Dao C, Habel J, Spicer T, Chase P, Baillargeon P, Scampavia L, Schürer S, Chung C, Mader C, Southern M, Tsinoremas N, LoGrasso P, Hodder P
September 24-26, 2008
“Development of a Small Molecule Probe of ROCK II Kinase Using HTRF® and Kinase Glo® Assay Technologies”
4th Annual Symposium: HTRF® in Drug Discovery
Avignon, France
41 – Spicer T
September 24-26, 2008
“Kinases in uHTS”
Kinase Session Chairperson, 4th Annual Symposium: HTRF® in Drug Discovery
Avignon, France
40 – DeLuca L
September 23, 2008
“Supporting an Expanding Medicinal Chemistry Portfolio”
IQPC 4th Compound Management Conference
Philadelphia, PA, USA
39 – Tabrizifard S, Obradovich D, Mandat S, Spicer T, Hodder P, McDonald PH
September 9-10, 2008
“Development of a Modified cAMP biosensor assay to identify Positive Allosteric Modulators of NPY-Y2 Receptor Activity”
Emerging Themes in GPCR Signaling & Drug Discovery, Functional Selectivity & Allosteric Modulation
Monona Terrace, Madison, WI, USA
38 – Longhurst K, Baillargeon P
July 23, 2008
“REMP Small-Size Store: The Website”
Scripps Florida Seminar
Jupiter, FL, USA
37 – Posner BA, Mandat S, Tabrizifard S, Spicer T, Hodder P, McDonald PH
May 18-23, 2008
“The Pfizer-TSRI Collaboration: Partnering for Success in Early Lead Discovery”
Keystone Symposium, G Protein-coupled Receptors New Insights in Functional Regulation and Clinical Application
Kilarney, Ireland
36 – Hodder P
2008
“Impacting Translational Research via uHTS: Discovery of Specific and Potent Chemical Probes via the Molecular Libraries Initiative”
The American Society for Cell Biology 48th Annual Meeting
San Francisco, CA, USA
35 – Tabrizifard S, Obradovich D, Mandat S, Spicer T, Hodder P, McDonald P
2008
“Development of a Modified cAMP Biosensor Assay to Identify Positive Allosteric Modulators of NPY-Y2 Receptor Activity”
Emerging Themes in GPCR Signaling & Drug Discovery, Functional Selectivity & Allosteric Modulation
Madison, WI, USA
34 – Roth J, Madoux F, Hodder P, Roush WR
2008
“Synthesis of Small Molecule Inhibitors of the Orphan Nuclear Receptor Steroidogenic Factor-1 (NR5A1) Based on Isoquinolinone Scaffolds”
236th ACS National Meeting
Philadelphia, PA, USA
33 – Hodder P
2008
“Discovery of Chemical Probes via High Throughput Screening”
The International Narcotics Research Conference (INRC-2008)
Charleston, SC, USA
32 – Hodder P
2008
“From uHTS to Chemical Probes: SF-1 Inhibitor Case Study”
Cambridge Healthtech Institute’s Cell-Based Assays for HTS Conference, Part of the World Pharmaceutical Congress
Philadelphia, PA, USA
31 – Calamini B, Madoux F, Saldanha S, West J, Fox SG, Maddry J, Hodder P, Morimoto RI
2008
“Small Molecule Screen for Activators of the Heat Shock Response”
Cold Spring Harbor Laboratory Molecular Chaperones & Stress Responses Group Meeting
Cold Spring Harbor, NY, USA
30 – Chase P
October 2007
“ViewLuxes in Florida: Sun-Screen SPF 1536”
PerkinElmer ViewLux User’s Group Meeting, Laboratory Robotics Interest Group Meeting
Philadelphia, PA, USA
29 – Baillargeon P
September 2007
“Supporting Medicinal Chemistry and HTS Efforts in an Academic Setting”
IQPC Compound Management and Integrity Conference
Philadelphia, PA, USA
28 – Madoux F
June 12-13, 2007
“Miniaturized, Transient Transfection-Based HTS Assays to Discover Orphan Nuclear Receptor Probes: A Case Study”
World Pharmaceutical Congress
Philadelphia, PA
27 – Hodder P
2007
“Academic and Industrial Roles in Drug Discovery”
The Automation Partnership (TAP) Chesapeake Conference
Cambridge, MD, USA
26 – Spicer T
2007
“Case Studies of uHTS Compatible Detection Formats for Kinase Assays”
3rd Annual Symposium: HTRF® in Drug Discovery
Sonoma, CA, USA
25 – Hodder P
2007
“Drug & Probe Discovery in Academia: Scripps Florida’s Translational Research Institute”
ILSI-Biomed Israel 2007 Conference
Tel-Aviv, Israel
24 – Hodder P
2007
“Creating a Centralized, Flexible Compound Management Operation”
Society for Biomolecular Screening 13th Annual Conference & Exhibition
Montréal, Canada
23 – Hodder P
November 2006
“uHTS Lead Identification at TSRI”
Corporate Club Group, The Governor’s Club
West Palm Beach, FL, USA
22 – Baillargeon P, Scampavia L
October 2006
“HTS Robotics and the Drug Discovery Process”
American Society of Mechanical Engineers (ASME)
Jupiter, FL, USA, Florida Atlantic University
21 – Hodder P
May 2006
“uHTS & Drug Discovery at Scripps Florida”
Keynote Speaker, Dade County Science Teachers’ Association Banquet
Miami, FL, USA
20 – Spicer T
2006
“Scripps Florida High Throughput Screening (HTS) Core Overview”
Florida Research Consortium Board Meeting
Tallahassee, FL, USA
19 – Spicer T
2006
“A Comparison of Luminescence and HTRF Detection Formats for Automated 1536 HTS of a Kinase Assay”
Laboratory and Robotics Interest Group (LRIG) Meeting
Philadelphia, PA, USA
18 – Hodder P
2005
“Constructing a uHTS Laboratory: A Case Study”
BioDiscovery Expo
17 – Hodder P
2005
“Overcoming the Limitations of the 384 Well Format: Implementation of 1536 Well Assays in a Centralized HTS Laboratory”
LabAutomation
San Jose, CA, USA
16 – Hodder P
2004
“Miniaturization of FLIPR Assays to 1536 Well Format”
The Laboratory Robotics Interest Group, 1st Annual Philadelphia Technology Exhibition & Presentations
Philadelphia, PA, USA
15 – Kotsonis P, Hodder P, Waldron G, Garcia-Guzman M, Goldbard S
2004
“Toward Higher-Throughput Robust, Quantitative and Miniaturizable Cell Based Assays”
The World Pharmaceutical Congress, Cell Based Assays for HTS
Philadelphia, PA, USA
14 – Zheng W, Hodder P
2003
“GPCR Pharmacology and Assay Technologies”
Society for Biomolecular Screening
International Web Presentation
13 – Hodder P
2003
“Automated HTS Campaigns in 1536 Well Format”
International Symposium on Lab Automation and Robotics
Boston, MA, USA
12 – Zheng W, Hodder P, Strulovici B
2003
“Introduction to Receptor Pharmacology”
Short Course Presentation, Society for Biomolecular Screening Annual Meeting
Portland, OR, USA
11 – Cassaday J, Kolodin G, Stec E, Berry K, Hoffman I, Hudak E, Strulovici B, Hodder P
2003
“A Custom Replicator for Improving Throughput of Compound Reformatting from 384 to 1536 Well Plates”
Society for Biomolecular Screening Annual Meeting
Portland, OR, USA
10 – Hodder P
2003
“Miniaturization of Intracellular Calcium FLIPR Assays to 1536 Well Format”
Molecular Devices 7th International User’s Meeting
Half Moon Bay, CA, USA
9 – Mull R, Cassaday J, Berry K, Strulovici B, Hodder P
2003
“Use of FLIPR384 to Compare Intracellular Calcium Responses with Fluo-4 and Fura Red dyes in Ratiometric Mode”
Molecular Devices 7th International User’s Meeting
Half Moon Bay, CA, USA
8 – Hodder P
September 2002
“Successful Implementation of Miniaturization Technologies for Lead Identification”
Society for Biomolecular Screening Annual Meeting
The Hague, The Netherlands
7 – Hodder P, Alberts M, Berry K, Cassaday J, Feighner S, Hoffman I, Howard A, Kornienko O, Lacson R, Schneeweis J, Smith T, Strulovici B
September 2002
“Comparison of Intracellular Calcium FLIPR HTS and Beta Lactamase Reporter Gene Assay UHTS”
Society for Biomolecular Screening Annual Meeting
The Hague, The Netherlands
6 – Stec E, Cassaday J, Berry K, Kolodin G, Strulovici B, Hodder P
2001
“Development of a Cell-Based Assay for 1536 Robotic High Throughput Screening”
Society for Biomolecular Screening Annual Meeting
Baltimore, MD, USA
5 – Kolodin G, Cassaday J, Berry K, Stec E, Strulovici B, Hodder P
2001
“Determination of Carryover in Robotic Cherry Picking Using a Sensitive Biological Assay”
Society for Biomolecular Screening Annual Meeting
Baltimore, MD, USA
4 – Cassaday J, Kolodin G, Stec E, Berry K, Strulovici B, Hodder P
2001
“A One-Armed Robotic System Optimization Algorithm (OARSOA) for the Design of Consistent Robotic Protocols for High-Throughput Screening Assays”
Society for Biomolecular Screening Annual Meeting
Baltimore, MD, USA
3 – Hodder P
2000
“Using Robolabs for FLIPR High Throughput Screening Assays: A Case Study”
Robolab User’s Group Meeting
Vancouver, Canada
2 – Hodder PS, Ruzicka J
1998
“A Flow Injection Renewable Surface Technique for Cell Based Drug-Discovery Assays”
International Conference on Flow Injection Analysis
Seattle, WA, USA
1 – Scampavia LD, Blankenstein G, Hodder PS, Ruzicka J, Christian GD
1995
“A Novel Coaxial Jet Mixer for Rapid Kinetic Assays in Flow Injection”
International Conference on Flow Injection Analysis
Seattle, WA, USA